Hemp-derived cannabidiol (CBD) has jumped to the forefront of the herbal remedies market in a short amount of time. This is partially due to the federal government’s new policies on hemp and hemp-related products.
Specifically, the December 2018 passing of the Agricultural Improvement Act of eased the regulations governing hemp products containing 0.3% or less of THC, the psychoactive chemical found in marijuana. With this reform, hemp with less than 0.3% THC is no longer a schedule 1 controlled substance. This has led to a boom in CBD products.
However, even though products containing CBD are legal in many states, state and federal regulations still govern them. At the same time, some states only allow limited use of CBD products. The FDA, which regulates nutritional and dietary supplements, regulates CBD in the same way that it regulates dietary supplements(1). To be specific, the FDA does not oversee the production or dietary supplements. However, the FDA can penalize manufacturers and marketers who make false of misleading claims about their products.
The AHP’s Latest Statement on CBD Products
The AHPA (American Herbal Products Association) is a national trade association which represents the herbal product industry. With over 350 companies on its membership roster, the AHPA promotes “the responsible commerce of herbal products to ensure that consumers continue to enjoy informed access to a wide variety of herbal goods.” Founded in 1982, its membership includes businesses involved in herb production, from growers to manufacturers to marketers (2).
In a recent statement, the AHPA sought to correct several erroneous views about CBD production, manufacturing, and distribution. According to the AHPA, a number of businesses in the CBD supply chain mistakenly believe that the FDA does not regulate hemp or CBD products. In its March 2019 Guidance Policy entitled Dietary supplements and food containing hemp and hemp-derived cannabidiol (CBD), the AHPA corrects that notion (3).
To date, the FDA has only approved a few CBD-derived, prescription drugs for a few specific treatments. Firstly, FDA-approved Epidiolex is a cannabis-derived anti-seizure medication (). Also, the FDA has approved three cannabis-related drug products:
- Marinol and Syndros – two medications used for treating “anorexia associated with weight loss in AIDS patients” (4).
- Cesamet – a medication used to treat nausea and vomiting caused by cancer chemotherapy treatments (5).
Apart from these specific medications for these specific conditions, no other uses have been FDA-approved. All the other CBD products on the shelves of your local retailer are non-pharmaceuitical CBD supplements, powders, creams, lotions, and other forms. That isn’t to say that any of these supplements or products are unsafe. Instead, it means that any medical claims are not yet backed by enough research to make them FDA-approved medications.
Fighting Misleading and False Claims About CBD Products
Depending on which marketing pitch consumers listen to, CBD treatment claims range from relieving aches and fighting inflammation to easing painful PMS symptoms. Regardless of the truthfulness of CBD product claims, people who use them seek a number of benefits. Some of these proposed benefits of CBD products include (6).
- Stop smoking
- For pain relief
- Reduce stress and anxiety
- Fight acne
- Treat autism
- Fight cancer
Yet, in spite of a handful medical studies, there still is little conclusive research to back up most of these claims. Consequently, one of the FDA’s main concerns is examining the claims of CBD products.
FDA Regulations Protect Consumers
The FDA certainly does scrutinize CBD products of all sorts like it does other nutritional supplements. Moreover, some companies have already been warned by the FDA for making wild and even false claims about CBD’s curative powers,
As such, the FDA’s role is to protect the public from harmful products or products with misleading claims. In light of this, FDA Commissioner Scott Gottlieb has encouraged retail stores and pharmacies early April to do their part to protect their customers from potentially risky products containing CBD (1).
What’s more, the AHPA encourages recommends that any company involved in the CBD supply chain should follow all federal regulations pertaining to their role. This includes following all the FDA’s agricultural, facility registration, manufacturing, labeling, and other regulations (7).
Getting the Highest Quality Herbal Supplements
ABH Pharma is a top tier herbal supplement manufacturer. What’s more, you can customize the size, appearance, and encapsulation material of your herbal products. Not only do we formulate and manufacture herbal and dietary supplements, we also bottle and label your product. In addition, we always follow all best manufacturing guidelines and always comply with all required FDA label regulations.
To learn more about our custom herbal supplement manufacturing process, Contact Us today or call call 1-855 232 8225 to speak with one of our Production Specialists.